CA2492783A1 - Method of transferring mutation into target nucleic acid - Google Patents
Method of transferring mutation into target nucleic acid Download PDFInfo
- Publication number
- CA2492783A1 CA2492783A1 CA002492783A CA2492783A CA2492783A1 CA 2492783 A1 CA2492783 A1 CA 2492783A1 CA 002492783 A CA002492783 A CA 002492783A CA 2492783 A CA2492783 A CA 2492783A CA 2492783 A1 CA2492783 A1 CA 2492783A1
- Authority
- CA
- Canada
- Prior art keywords
- dna
- sequence
- nucleic acid
- gene
- irdna
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 238000000034 method Methods 0.000 title claims abstract description 64
- 230000035772 mutation Effects 0.000 title claims abstract description 62
- 102000039446 nucleic acids Human genes 0.000 title claims abstract description 58
- 108020004707 nucleic acids Proteins 0.000 title claims abstract description 58
- 150000007523 nucleic acids Chemical class 0.000 title claims abstract description 58
- 108020004414 DNA Proteins 0.000 claims description 162
- 108090000623 proteins and genes Proteins 0.000 claims description 151
- 210000004027 cell Anatomy 0.000 claims description 110
- 125000003729 nucleotide group Chemical group 0.000 claims description 104
- 239000002773 nucleotide Substances 0.000 claims description 99
- 102000004169 proteins and genes Human genes 0.000 claims description 55
- 230000027455 binding Effects 0.000 claims description 40
- 102000053602 DNA Human genes 0.000 claims description 16
- 108091023040 Transcription factor Proteins 0.000 claims description 16
- 102000040945 Transcription factor Human genes 0.000 claims description 16
- 230000025308 nuclear transport Effects 0.000 claims description 16
- 210000000805 cytoplasm Anatomy 0.000 claims description 10
- 108020004682 Single-Stranded DNA Proteins 0.000 claims description 9
- 238000006467 substitution reaction Methods 0.000 claims description 6
- 238000012217 deletion Methods 0.000 claims description 4
- 230000037430 deletion Effects 0.000 claims description 4
- 238000003780 insertion Methods 0.000 claims description 3
- 230000037431 insertion Effects 0.000 claims description 3
- 230000003252 repetitive effect Effects 0.000 abstract 3
- 230000008439 repair process Effects 0.000 description 55
- 239000012634 fragment Substances 0.000 description 36
- 239000005090 green fluorescent protein Substances 0.000 description 34
- 239000013612 plasmid Substances 0.000 description 33
- 210000004940 nucleus Anatomy 0.000 description 15
- 101150066002 GFP gene Proteins 0.000 description 14
- 108091034117 Oligonucleotide Proteins 0.000 description 12
- 230000000694 effects Effects 0.000 description 12
- 108091028043 Nucleic acid sequence Proteins 0.000 description 11
- 238000012546 transfer Methods 0.000 description 11
- 238000002474 experimental method Methods 0.000 description 10
- 230000000692 anti-sense effect Effects 0.000 description 9
- 239000013598 vector Substances 0.000 description 9
- 125000002637 deoxyribonucleotide group Chemical group 0.000 description 8
- 238000001415 gene therapy Methods 0.000 description 8
- 238000001890 transfection Methods 0.000 description 8
- 239000005547 deoxyribonucleotide Substances 0.000 description 7
- 210000003958 hematopoietic stem cell Anatomy 0.000 description 7
- 125000002652 ribonucleotide group Chemical group 0.000 description 7
- 101710163270 Nuclease Proteins 0.000 description 6
- 230000015572 biosynthetic process Effects 0.000 description 6
- 239000013642 negative control Substances 0.000 description 6
- 238000000585 Mann–Whitney U test Methods 0.000 description 5
- 230000015556 catabolic process Effects 0.000 description 5
- 210000000349 chromosome Anatomy 0.000 description 5
- 238000006731 degradation reaction Methods 0.000 description 5
- 239000000203 mixture Substances 0.000 description 5
- 241001430294 unidentified retrovirus Species 0.000 description 5
- 108091032973 (ribonucleotides)n+m Proteins 0.000 description 4
- 108091028664 Ribonucleotide Proteins 0.000 description 4
- 108091081021 Sense strand Proteins 0.000 description 4
- 108091081024 Start codon Proteins 0.000 description 4
- 241000700605 Viruses Species 0.000 description 4
- 230000003321 amplification Effects 0.000 description 4
- 239000000463 material Substances 0.000 description 4
- 238000002703 mutagenesis Methods 0.000 description 4
- 231100000350 mutagenesis Toxicity 0.000 description 4
- 238000003199 nucleic acid amplification method Methods 0.000 description 4
- 238000002360 preparation method Methods 0.000 description 4
- 239000002336 ribonucleotide Substances 0.000 description 4
- 230000008685 targeting Effects 0.000 description 4
- 241000282414 Homo sapiens Species 0.000 description 3
- 241001465754 Metazoa Species 0.000 description 3
- 108020005038 Terminator Codon Proteins 0.000 description 3
- 125000000539 amino acid group Chemical group 0.000 description 3
- 239000003153 chemical reaction reagent Substances 0.000 description 3
- 239000013611 chromosomal DNA Substances 0.000 description 3
- 230000000295 complement effect Effects 0.000 description 3
- 238000009792 diffusion process Methods 0.000 description 3
- 210000004700 fetal blood Anatomy 0.000 description 3
- 230000014509 gene expression Effects 0.000 description 3
- 238000003505 heat denaturation Methods 0.000 description 3
- 238000004519 manufacturing process Methods 0.000 description 3
- 230000007246 mechanism Effects 0.000 description 3
- 230000033607 mismatch repair Effects 0.000 description 3
- 238000003786 synthesis reaction Methods 0.000 description 3
- 238000011144 upstream manufacturing Methods 0.000 description 3
- 230000004568 DNA-binding Effects 0.000 description 2
- 108090000790 Enzymes Proteins 0.000 description 2
- 102000004190 Enzymes Human genes 0.000 description 2
- 108010043121 Green Fluorescent Proteins Proteins 0.000 description 2
- 102000008300 Mutant Proteins Human genes 0.000 description 2
- 108010021466 Mutant Proteins Proteins 0.000 description 2
- 108091081062 Repeated sequence (DNA) Proteins 0.000 description 2
- 108060008682 Tumor Necrosis Factor Proteins 0.000 description 2
- 102100040247 Tumor necrosis factor Human genes 0.000 description 2
- 229910000389 calcium phosphate Inorganic materials 0.000 description 2
- 239000001506 calcium phosphate Substances 0.000 description 2
- 235000011010 calcium phosphates Nutrition 0.000 description 2
- 230000001413 cellular effect Effects 0.000 description 2
- 238000006243 chemical reaction Methods 0.000 description 2
- 239000012228 culture supernatant Substances 0.000 description 2
- 238000012258 culturing Methods 0.000 description 2
- 230000002255 enzymatic effect Effects 0.000 description 2
- 238000010230 functional analysis Methods 0.000 description 2
- 238000010363 gene targeting Methods 0.000 description 2
- 238000000338 in vitro Methods 0.000 description 2
- 230000003834 intracellular effect Effects 0.000 description 2
- 230000001404 mediated effect Effects 0.000 description 2
- 210000005087 mononuclear cell Anatomy 0.000 description 2
- 238000004806 packaging method and process Methods 0.000 description 2
- 210000005259 peripheral blood Anatomy 0.000 description 2
- 239000011886 peripheral blood Substances 0.000 description 2
- 230000010076 replication Effects 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 238000013518 transcription Methods 0.000 description 2
- 230000035897 transcription Effects 0.000 description 2
- 238000013519 translation Methods 0.000 description 2
- 238000002054 transplantation Methods 0.000 description 2
- QORWJWZARLRLPR-UHFFFAOYSA-H tricalcium bis(phosphate) Chemical compound [Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O QORWJWZARLRLPR-UHFFFAOYSA-H 0.000 description 2
- SXUXMRMBWZCMEN-UHFFFAOYSA-N 2'-O-methyl uridine Natural products COC1C(O)C(CO)OC1N1C(=O)NC(=O)C=C1 SXUXMRMBWZCMEN-UHFFFAOYSA-N 0.000 description 1
- SXUXMRMBWZCMEN-ZOQUXTDFSA-N 2'-O-methyluridine Chemical compound CO[C@@H]1[C@H](O)[C@@H](CO)O[C@H]1N1C(=O)NC(=O)C=C1 SXUXMRMBWZCMEN-ZOQUXTDFSA-N 0.000 description 1
- 102000015280 CCAAT-Enhancer-Binding Protein-beta Human genes 0.000 description 1
- 108010064535 CCAAT-Enhancer-Binding Protein-beta Proteins 0.000 description 1
- 101710186200 CCAAT/enhancer-binding protein Proteins 0.000 description 1
- 108020004705 Codon Proteins 0.000 description 1
- 102000004127 Cytokines Human genes 0.000 description 1
- 108090000695 Cytokines Proteins 0.000 description 1
- 230000006820 DNA synthesis Effects 0.000 description 1
- 102000004163 DNA-directed RNA polymerases Human genes 0.000 description 1
- 108090000626 DNA-directed RNA polymerases Proteins 0.000 description 1
- 102000002322 Egg Proteins Human genes 0.000 description 1
- 108010000912 Egg Proteins Proteins 0.000 description 1
- 241000588724 Escherichia coli Species 0.000 description 1
- 101150031329 Ets1 gene Proteins 0.000 description 1
- 241000287828 Gallus gallus Species 0.000 description 1
- 102000004144 Green Fluorescent Proteins Human genes 0.000 description 1
- 108010033040 Histones Proteins 0.000 description 1
- 241000282412 Homo Species 0.000 description 1
- 101000837829 Homo sapiens Transcription factor IIIA Proteins 0.000 description 1
- 208000026350 Inborn Genetic disease Diseases 0.000 description 1
- 101710128836 Large T antigen Proteins 0.000 description 1
- 239000012097 Lipofectamine 2000 Substances 0.000 description 1
- 108020005196 Mitochondrial DNA Proteins 0.000 description 1
- -1 NF-KB Proteins 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 102000015863 Nuclear Factor 90 Proteins Human genes 0.000 description 1
- 108010010424 Nuclear Factor 90 Proteins Proteins 0.000 description 1
- 102000002488 Nucleoplasmin Human genes 0.000 description 1
- 241000276569 Oryzias latipes Species 0.000 description 1
- 238000012408 PCR amplification Methods 0.000 description 1
- 102100035593 POU domain, class 2, transcription factor 1 Human genes 0.000 description 1
- 101710084414 POU domain, class 2, transcription factor 1 Proteins 0.000 description 1
- 230000018199 S phase Effects 0.000 description 1
- 238000012300 Sequence Analysis Methods 0.000 description 1
- 108010042291 Serum Response Factor Proteins 0.000 description 1
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical group [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 description 1
- 101001062859 Sus scrofa Fatty acid-binding protein, adipocyte Proteins 0.000 description 1
- 210000001744 T-lymphocyte Anatomy 0.000 description 1
- 239000007984 Tris EDTA buffer Substances 0.000 description 1
- ISAKRJDGNUQOIC-UHFFFAOYSA-N Uracil Chemical group O=C1C=CNC(=O)N1 ISAKRJDGNUQOIC-UHFFFAOYSA-N 0.000 description 1
- 108091005971 Wild-type GFP Proteins 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- 230000003213 activating effect Effects 0.000 description 1
- 230000009056 active transport Effects 0.000 description 1
- 210000003719 b-lymphocyte Anatomy 0.000 description 1
- 230000037429 base substitution Effects 0.000 description 1
- 210000000601 blood cell Anatomy 0.000 description 1
- 210000001185 bone marrow Anatomy 0.000 description 1
- 210000002798 bone marrow cell Anatomy 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 230000010261 cell growth Effects 0.000 description 1
- 239000002458 cell surface marker Substances 0.000 description 1
- 108091092356 cellular DNA Proteins 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 230000002759 chromosomal effect Effects 0.000 description 1
- 238000010367 cloning Methods 0.000 description 1
- 238000010276 construction Methods 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- 238000004925 denaturation Methods 0.000 description 1
- 230000036425 denaturation Effects 0.000 description 1
- 238000000432 density-gradient centrifugation Methods 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- 230000034431 double-strand break repair via homologous recombination Effects 0.000 description 1
- 238000004520 electroporation Methods 0.000 description 1
- 210000001671 embryonic stem cell Anatomy 0.000 description 1
- 238000006911 enzymatic reaction Methods 0.000 description 1
- 239000013604 expression vector Substances 0.000 description 1
- 210000002950 fibroblast Anatomy 0.000 description 1
- 230000037433 frameshift Effects 0.000 description 1
- 102000037865 fusion proteins Human genes 0.000 description 1
- 108020001507 fusion proteins Proteins 0.000 description 1
- 238000003209 gene knockout Methods 0.000 description 1
- 208000016361 genetic disease Diseases 0.000 description 1
- 210000004602 germ cell Anatomy 0.000 description 1
- 210000003494 hepatocyte Anatomy 0.000 description 1
- 238000002744 homologous recombination Methods 0.000 description 1
- 230000006801 homologous recombination Effects 0.000 description 1
- 239000005457 ice water Substances 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 238000010348 incorporation Methods 0.000 description 1
- 230000010354 integration Effects 0.000 description 1
- 238000001990 intravenous administration Methods 0.000 description 1
- 208000032839 leukemia Diseases 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 239000002502 liposome Substances 0.000 description 1
- 230000004807 localization Effects 0.000 description 1
- 210000004698 lymphocyte Anatomy 0.000 description 1
- 238000012423 maintenance Methods 0.000 description 1
- 230000014759 maintenance of location Effects 0.000 description 1
- 210000003098 myoblast Anatomy 0.000 description 1
- 210000003757 neuroblast Anatomy 0.000 description 1
- 210000002569 neuron Anatomy 0.000 description 1
- 108060005597 nucleoplasmin Proteins 0.000 description 1
- 210000000287 oocyte Anatomy 0.000 description 1
- 210000002380 oogonia Anatomy 0.000 description 1
- 210000004681 ovum Anatomy 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- 125000002467 phosphate group Chemical group [H]OP(=O)(O[H])O[*] 0.000 description 1
- 239000013600 plasmid vector Substances 0.000 description 1
- 238000003752 polymerase chain reaction Methods 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 230000002035 prolonged effect Effects 0.000 description 1
- 210000005132 reproductive cell Anatomy 0.000 description 1
- 108091008146 restriction endonucleases Proteins 0.000 description 1
- 238000012216 screening Methods 0.000 description 1
- 208000007056 sickle cell anemia Diseases 0.000 description 1
- 230000019491 signal transduction Effects 0.000 description 1
- 210000002363 skeletal muscle cell Anatomy 0.000 description 1
- 210000000329 smooth muscle myocyte Anatomy 0.000 description 1
- 125000006850 spacer group Chemical group 0.000 description 1
- 210000000130 stem cell Anatomy 0.000 description 1
- 239000011593 sulfur Substances 0.000 description 1
- 229910052717 sulfur Inorganic materials 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- RWQNBRDOKXIBIV-UHFFFAOYSA-N thymine Chemical group CC1=CNC(=O)NC1=O RWQNBRDOKXIBIV-UHFFFAOYSA-N 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 238000003151 transfection method Methods 0.000 description 1
- 230000009261 transgenic effect Effects 0.000 description 1
- 230000032258 transport Effects 0.000 description 1
- OUYCCCASQSFEME-UHFFFAOYSA-N tyrosine Natural products OC(=O)C(N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-UHFFFAOYSA-N 0.000 description 1
- 125000001493 tyrosinyl group Chemical group [H]OC1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])C([H])(N([H])[H])C(*)=O 0.000 description 1
- 210000003556 vascular endothelial cell Anatomy 0.000 description 1
- 108700026220 vif Genes Proteins 0.000 description 1
- MECHNRXZTMCUDQ-RKHKHRCZSA-N vitamin D2 Chemical compound C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)/C=C/[C@H](C)C(C)C)=C\C=C1\C[C@@H](O)CCC1=C MECHNRXZTMCUDQ-RKHKHRCZSA-N 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/43504—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates
- C07K14/43595—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates from coelenteratae, e.g. medusae
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
- C12N15/102—Mutagenizing nucleic acids
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Genetics & Genomics (AREA)
- Zoology (AREA)
- Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Molecular Biology (AREA)
- Biophysics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- Wood Science & Technology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Medicinal Chemistry (AREA)
- Microbiology (AREA)
- Crystallography & Structural Chemistry (AREA)
- Plant Pathology (AREA)
- Toxicology (AREA)
- Gastroenterology & Hepatology (AREA)
- Physics & Mathematics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Peptides Or Proteins (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Compounds Of Unknown Constitution (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Saccharide Compounds (AREA)
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2002-204887 | 2002-07-12 | ||
| JP2002204887 | 2002-07-12 | ||
| JP2003113534 | 2003-04-18 | ||
| JP2003-113534 | 2003-04-18 | ||
| PCT/JP2003/008816 WO2004007715A1 (ja) | 2002-07-12 | 2003-07-11 | 標的核酸への変異の導入方法 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CA2492783A1 true CA2492783A1 (en) | 2004-01-22 |
Family
ID=30117458
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA002492783A Abandoned CA2492783A1 (en) | 2002-07-12 | 2003-07-11 | Method of transferring mutation into target nucleic acid |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US20060160219A1 (enExample) |
| EP (1) | EP1533375B1 (enExample) |
| JP (1) | JP4372684B2 (enExample) |
| CN (1) | CN100540664C (enExample) |
| AT (1) | ATE443134T1 (enExample) |
| AU (1) | AU2003248268A1 (enExample) |
| CA (1) | CA2492783A1 (enExample) |
| DE (1) | DE60329302D1 (enExample) |
| TW (1) | TW200411052A (enExample) |
| WO (1) | WO2004007715A1 (enExample) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20060189560A1 (en) * | 2005-01-27 | 2006-08-24 | Ajit Kumar | Molecular method to augment RNA mediated gene silencing |
| US9276664B2 (en) | 2007-04-30 | 2016-03-01 | Dish Network Corporation | Mobile interactive satellite services |
| US8457682B2 (en) | 2008-03-04 | 2013-06-04 | Dbsd Satellite Services G.P. | Method and system for integrated satellite assistance services |
| US8626230B2 (en) | 2008-03-04 | 2014-01-07 | Dish Network Corporation | Method and system for using routine driving information in mobile interactive satellite services |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2073630C (en) * | 1991-08-30 | 2007-12-11 | Atsushi Ohshima | Method for synthesizing single-stranded stem-loop dnas, the products and uses therefor |
| WO1998040510A1 (en) * | 1997-03-11 | 1998-09-17 | Regents Of The University Of Minnesota | Dna-based transposon system for the introduction of nucleic acid into dna of a cell |
| US6130207A (en) * | 1997-11-05 | 2000-10-10 | South Alabama Medical Science Foundation | Cell-specific molecule and method for importing DNA into a nucleus |
| AUPP249298A0 (en) * | 1998-03-20 | 1998-04-23 | Ag-Gene Australia Limited | Synthetic genes and genetic constructs comprising same I |
| EP1181382B1 (en) * | 1999-06-01 | 2005-03-23 | The University of Washington | Recombinant adenoviral vectors expressing chimeric fiber proteins for cell specific infection and genome integration |
| WO2001049844A1 (en) * | 1999-12-30 | 2001-07-12 | Rutgers, The State University Of New Jersey | Compositions and methods for gene silencing |
-
2003
- 2003-07-10 TW TW092118857A patent/TW200411052A/zh not_active IP Right Cessation
- 2003-07-11 US US10/520,008 patent/US20060160219A1/en not_active Abandoned
- 2003-07-11 AT AT03764168T patent/ATE443134T1/de not_active IP Right Cessation
- 2003-07-11 DE DE60329302T patent/DE60329302D1/de not_active Expired - Fee Related
- 2003-07-11 CA CA002492783A patent/CA2492783A1/en not_active Abandoned
- 2003-07-11 AU AU2003248268A patent/AU2003248268A1/en not_active Abandoned
- 2003-07-11 CN CNB038165678A patent/CN100540664C/zh not_active Expired - Fee Related
- 2003-07-11 JP JP2004521183A patent/JP4372684B2/ja not_active Expired - Fee Related
- 2003-07-11 EP EP03764168A patent/EP1533375B1/en not_active Expired - Lifetime
- 2003-07-11 WO PCT/JP2003/008816 patent/WO2004007715A1/ja not_active Ceased
Also Published As
| Publication number | Publication date |
|---|---|
| EP1533375A4 (en) | 2005-08-31 |
| JP4372684B2 (ja) | 2009-11-25 |
| JPWO2004007715A1 (ja) | 2005-11-10 |
| ATE443134T1 (de) | 2009-10-15 |
| DE60329302D1 (de) | 2009-10-29 |
| TW200411052A (en) | 2004-07-01 |
| US20060160219A1 (en) | 2006-07-20 |
| WO2004007715A1 (ja) | 2004-01-22 |
| EP1533375B1 (en) | 2009-09-16 |
| EP1533375A1 (en) | 2005-05-25 |
| AU2003248268A1 (en) | 2004-02-02 |
| TWI316958B (enExample) | 2009-11-11 |
| CN1668743A (zh) | 2005-09-14 |
| CN100540664C (zh) | 2009-09-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP3585238B2 (ja) | 真核細胞における部位特異的突然変異誘発のための化合物および方法 | |
| AU773242B2 (en) | Genetic alteration in plants using single-stranded oligonucleotide vectors | |
| AU2020272668A1 (en) | Integration of nucleic acid constructs into eukaryotic cells with a transposase from oryzias | |
| EP3523430A1 (en) | Engineered nuceic acid-targeting nucleic acids | |
| CA3066599A1 (en) | Method for producing dna-edited eukaryotic cell, and kit used in the same | |
| AU2020272667A1 (en) | Transposition of nucleic acid constructs into eukaryotic genomes with a transposase from amyelois | |
| EP3974524A1 (en) | Dna vectors, transposons and transposases for eukaryotic genome modification | |
| EP0593580A4 (en) | Sequences characteristic of human gene transcription product | |
| KR20220128644A (ko) | 게놈 변형을 위한 높은 충실도 SpCas9 뉴클라제 | |
| JP2005518817A (ja) | ヒストン・デアセチラーゼ・インヒビタ、ラムダファージベータ蛋白、またはヒドロキシウレアを含む組成物を使用してオリゴヌクレオチド媒介性核酸配列改変を高める方法、組成物およびキット | |
| EP1533375B1 (en) | Method of transferring mutation into target nucleic acid | |
| KR20050021366A (ko) | 표적 핵산내 돌연변이 도입 방법 | |
| HK40038501B (zh) | 使用来自青鱂属的转座酶将核酸构建体整合入真核细胞 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| EEER | Examination request | ||
| FZDE | Discontinued |